FindTrial
Sign In

Identification of proteomic and genomic bio-markers for diagnosis of tuberculosis from clinical samples.

Omics analysis of Tuberculosis infections and resistance determination

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/10/016109
Enrollment
150
Registered
2018-10-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A159- Respiratory tuberculosis unspecified Health Condition 2: A188- Tuberculosis of other specified organs

Interventions

Intervention1: Bronchoscopy Spinal Tap Biopsy: Bronchoscopy: for collection of bronchoalveolar lavage sample for TB diagnosis. Spinal Tap: for collection of Cerebrospinal fluid for TB diagnosis. Biop

Sponsors

Wellcome Trust DBT and Institute of Bioinformatics Bangalore
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients suspected of tuberculosis (Pulmonary and extra-pulmonary tuberculosis both) between 18 years to 60 years of age.

Exclusion criteria

Exclusion criteria: Patients who have refused to give consent and pregnant women will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
The proteomic and genomic data generated in the present study would help in the development of better and more efficient diagnostic methods for future use.Timepoint: 3 years—

Secondary

MeasureTime frame
present study will provide the genomic data on drug resistance among TB isolatesTimepoint: 3 years—

Countries

India

Contacts

Public ContactKiran Chawla

Kasturba Medical College Manipal

kiran.chawla@manipal.edu08202922717

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026